insights_auto
Why is MRNA up 12.27%?
Dive Deeperchevron_right
MRNA:NASDAQ
Moderna Inc
$172.94
arrow_upward
+12.27%(+18.90) 1D
$172.50
arrow_downward
-0.25% (-0.44)bedtimeAfter hours
Closed: Sep 21, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
$161.05
High
$176.86
Low
$159.06
Mkt. cap
69.04B
Avg. vol.
26.20M
Volume
20.97M
52-wk high
$176.86
52-wk low
$22.29
EPS
-$7.98
Beta
1.10
Shares outstanding
399.24M
No. of employees
5K
Open
$161.05
High
$176.86
Low
$159.06
Mkt. cap
69.04B
Avg. vol.
26.20M
Volume
20.97M
52-wk high
$176.86
52-wk low
$22.29
EPS
-$7.98
Beta
1.10
Shares outstanding
399.24M
No. of employees
5K
News stories
From web sources and news partners
Seeking Alpha
·
1 hour ago
Stocks to watch on Monday after hours: MRNA, ARM, and PBF
News Corp
·
2 hours ago
Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
Moomoo
·
2 hours ago
Moderna Stock Jumps 10%+. Its MRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.
StocksToTrade
·
3 hours ago
Moderna Stock Surges As FDA Approval And Oncology Wins Fuel Rally
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc